UB Paderborn / Katalog / Suche / in CDI

Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.

1 – 25 von 85

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer

Oncotarget, 2017-01, Vol.8 (4), p.6540-6554

2017

Volltextzugriff (PDF)

Targeting prostaglandin E EP receptors to inhibit metastasis

Cancer research (Chicago, Ill.), 2006-10, Vol.66 (20), p.9794-9797

2006

Volltextzugriff (PDF)

An Extract of Taro (Colocasia esculenta) Mediates Potent Inhibitory Actions on Metastatic and Cancer Stem Cells by Tumor Cell-Autonomous and Immune-Dependent Mechanisms

Breast cancer : basic and clinical research, 2021-01, Vol.15, p.11782234211034937-11782234211034937

2021

Volltextzugriff (PDF)

The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells

Breast cancer : basic and clinical research, 2019, Vol.13, p.1178223419873628-1178223419873628

2019

Volltextzugriff (PDF)

Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer

Cancer research (Chicago, Ill.), 2006-08, Vol.66 (15), p.7701-7707

2006

Volltextzugriff (PDF)

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

Molecular cancer therapeutics, 2009-03, Vol.8 (3), p.490-498

2009

Volltextzugriff (PDF)

Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis

Cancer research (Chicago, Ill.), 2006-03, Vol.66 (6), p.2923-2927

2006

Volltextzugriff (PDF)

Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function

Breast cancer research and treatment, 2009-09, Vol.117 (2), p.235-242

2009

Volltextzugriff (PDF)

Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model

Journal of immunotherapy, 2007-07, Vol.30 (5), p.490-498

2007

Volltextzugriff (PDF)

Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities

Molecular cancer research, 2010-10, Vol.8 (10), p.1310-1318

2010

Volltextzugriff (PDF)

Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4

Cancer Immunology, Immunotherapy, 2011-11, Vol.60 (11), p.1577-1586

2011

Volltextzugriff (PDF)

Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4

Journal of immunotherapy (1997), 2012-02, Vol.35 (2), p.179-188

2012

Volltextzugriff (PDF)

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

Breast cancer research and treatment, 2014-01, Vol.143 (1), p.19-31

2014

Volltextzugriff (PDF)

Abstract 4770: Novel CXCR3 allosteric modulators inhibit breast cancer stem cells and metastasis

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4770-4770

2017

Volltextzugriff (PDF)

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis

Oncoimmunology, 2013-01, Vol.2 (1), p.e22647-e22647

2013

Volltextzugriff (PDF)

Abstract P2-06-03: Prostaglandin E receptor EP4 is a therapeutic target in breast cancer stem cells

Cancer research (Chicago, Ill.), 2015-05, Vol.75 (9_Supplement), p.P2-P2-06-03

2015

Volltextzugriff (PDF)

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis

Breast cancer research and treatment, 2015-01, Vol.149 (2), p.403-415

2015

Volltextzugriff (PDF)

Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2

Breast cancer research and treatment, 2012-04, Vol.132 (3), p.1001-1008

2012

Volltextzugriff (PDF)

Abstract 4132: Multiple drug resistance-associated protein 4 (MRP4): Role in triple negative breast cancer

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.4132-4132

2016

Volltextzugriff (PDF)

Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer

Cancer research (Chicago, Ill.), 2002-04, Vol.62 (8), p.2343-2346

2002

Volltextzugriff (PDF)

Abstract 2233: The prostaglandin E receptor EP4 is upregulated on breast cancer stem-like cells and regulates sensitivity to Natural Killer cells

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2233-2233

2015

Volltextzugriff (PDF)

Abstract 2257: Multiple drug resistance-associated protein 4 (MRP4) may contribute to breast cancer metastasis by exporting the COX-2 product PGE2

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.2257-2257

2015

Volltextzugriff (PDF)

Abstract 1531: Distinct roles of CXCR3 isoforms in promoting breast cancer stem-like cell properties and metastasis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1531-1531

2015

Volltextzugriff (PDF)

Abstract 3250: Prostaglandin E2 receptor EP1 suppresses breast cancer metastasis

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.3250-3250

2015

Volltextzugriff (PDF)

Divergent Roles of CXCR3 Isoforms in Promoting Cancer Stem Cell Survival and Metastasis

Breast cancer research and treatment, 2014-12, Vol.149 (2), p.403-415

2014

Volltextzugriff (PDF)

1 – 25 von 85

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(76)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(82)
Buchkapitel
(3)

Sprache

Englisch
(85)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multiple drug resistance-associated protein (MRP4) exports prostaglandin E2 (PGE2) and contributes to metastasis in basal/triple negative breast cancer

Targeting prostaglandin E EP receptors to inhibit metastasis

An Extract of Taro (Colocasia esculenta) Mediates Potent Inhibitory Actions on Metastatic and Cancer Stem Cells by Tumor Cell-Autonomous and Immune-Dependent Mechanisms

The Chemokine Receptor CXCR3 Isoform B Drives Breast Cancer Stem Cells

Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

Prostaglandin E receptor EP4 antagonism inhibits breast cancer metastasis

Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function

Immune-mediated modulation of breast cancer growth and metastasis by the chemokine Mig (CXCL9) in a murine model

Prostaglandin E receptor EP1 suppresses breast cancer metastasis and is linked to survival differences and cancer disparities

Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4

Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4

Prostaglandin E receptor EP4 is a therapeutic target in breast cancer cells with stem-like properties

Abstract 4770: Novel CXCR3 allosteric modulators inhibit breast cancer stem cells and metastasis

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis

Abstract P2-06-03: Prostaglandin E receptor EP4 is a therapeutic target in breast cancer stem cells

Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis

Frondoside A inhibits breast cancer metastasis and antagonizes prostaglandin E receptors EP4 and EP2

Abstract 4132: Multiple drug resistance-associated protein 4 (MRP4): Role in triple negative breast cancer

Selective cyclooxygenase (COX)-1 or COX-2 inhibitors control metastatic disease in a murine model of breast cancer

Abstract 2233: The prostaglandin E receptor EP4 is upregulated on breast cancer stem-like cells and regulates sensitivity to Natural Killer cells

Abstract 2257: Multiple drug resistance-associated protein 4 (MRP4) may contribute to breast cancer metastasis by exporting the COX-2 product PGE2

Abstract 1531: Distinct roles of CXCR3 isoforms in promoting breast cancer stem-like cell properties and metastasis

Abstract 3250: Prostaglandin E2 receptor EP1 suppresses breast cancer metastasis

Divergent Roles of CXCR3 Isoforms in Promoting Cancer Stem Cell Survival and Metastasis

Suchergebnisse filtern